Uveal Melanoma

• Gemcitabine 1000 / Treosulfan 3.5, malignant Uveal Melanoma PID 1160 V1.1 (2026-08-26)
  V1.1: Correction to infusion duration V1.0: Cato test done. V0.1: Created by A. Dresel; Gemcitabine infusion duration based on Keilholz 2004; Treosulfan infusion duration as a short infusion according to the summary of product characteristics.

Ovarian Tumor

• Treosulfan 7, Ovarian ca PID 863 V1.2 (2026-08-26)
  V1.2: Corrected infusion duration. V1.1: Added the UID to the body surface area (g/m²) for another Cato import. V1.0: Cato test done. V0.1: Runtime according to the summary of product characteristics.

Protocols in Revision

Ewing Sarcoma

• Busulfan 0.8 / Melphalan 140, Ewing Sarcoma, Autologous Stem Cell Transplantation PID 571 V1.2
• Busulfan 3,2 / Melphalan 140, Ewing Sarkom, autologe Stammzelltransplantation PID 76 V1.1

Hodgkin Lymphoma

• BEAM - Carmustin 300 / Etoposid 200 / Cytarabin 200 / Melphalan 140, autologe Stammzelltransplantation PID 280 V2.2

Breast Cancer

• Tucatinib 300 / Capecitabine 1000 / Trastuzumab 600, Breast Cancer PID 1763 V1.2

Mantle Cell Lymphoma

• BEAM - Carmustin 300 / Etoposid 200 / Cytarabin 200 / Melphalan 140, autologe Stammzelltransplantation PID 280 V2.2

Multiple Myeloma

• Belantamab Mafodotin 1,9 / Pomalidomid 4 / Dexamethason 40, multiples Myelom, Zyklus 2+ PID 2675 V1.1
• Belantamab Mafodotin 2,5 / Pomalidomid 4 / Dexamethason 40, multiples Myelom, Zyklus 1 PID 2674 V1.1
• DREAMM-7 - Belantamab Mafodotin 2,5 / Bortezomib 1,3 / Dexamethason 20 - Belantamab Mafodotin 2,5, multiples Myelom, Zyklus 9+ PID 3175 V1.1
• DREAMM-7 - Belantamab Mafodotin 2,5 / Bortezomib 1,3 / Dexamethason 20, multiples Myelom, Zyklus 1-8 PID 3174 V1.1
• HD 7 - Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20, Multiple Myeloma, Induction, Cycle 1-3 PID 40 V1.1
• HD 7 - Lenalidomide 10 / Dexamethasone 20, Multiple Myeloma, maintenance, cycle 1 PID 43 V1.1
• HD 7 - Lenalidomide 10, multiple myeloma, maintenance, cycle 2-3 PID 44 V1.1
• HD 7 - Lenalidomide 15, multiple myeloma, maintenance, cycle 4+ PID 37 V1.1
• Melphalan 100, multiples Myelom, autologe Stammzelltransplantation PID 528 V2.3

NHL, B-Cell Type, Diffuse Large Cell

• BEAM - Carmustin 300 / Etoposid 200 / Cytarabin 200 / Melphalan 140, autologe Stammzelltransplantation PID 280 V2.2

NHL, B-Cell Type, Follicular grade IIIb

• BEAM - Carmustin 300 / Etoposid 200 / Cytarabin 200 / Melphalan 140, autologe Stammzelltransplantation PID 280 V2.2

Ovarian Tumor

• Mirvetuximab soravtansine 6, Ovarian Carcinoma PID 2606 V1.2

Stem Cell Transplantation, Autologous

• BEAM - Carmustin 300 / Etoposid 200 / Cytarabin 200 / Melphalan 140, autologe Stammzelltransplantation PID 280 V2.2
• Busulfan 0.8 / Melphalan 140, Ewing Sarcoma, Autologous Stem Cell Transplantation PID 571 V1.2
• Busulfan 3,2 / Melphalan 140, Ewing Sarkom, autologe Stammzelltransplantation PID 76 V1.1
• Melphalan 100, multiples Myelom, autologe Stammzelltransplantation PID 528 V2.3

Cervical Cancer

• Tisotumab Vedotin 2, Cervical Carcinoma PID 2002 V1.1